ADVAXIS
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ADVAXIS and buy or sell other stocks, ETFs, and their options commission-free!About ADXS
Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in developing and commercializing small molecule therapeutics for patients suffering from rare tumors and aggressive cancers. Its lead candidates are the oral gamma secretase inhibitor, AL102, for desmoid tumors, and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia.
CEOKen Berlin
CEOKen Berlin
Employees—
Employees—
HeadquartersMonmouth Junction, New Jersey
HeadquartersMonmouth Junction, New Jersey
Founded2017
Founded2017
Employees—
Employees—
ADXS Key Statistics
Market cap25.73M
Market cap25.73M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume14.19K
Average volume14.19K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.801
52 Week high$0.801
52 Week low$0.0011
52 Week low$0.0011
Stock Snapshot
With a market cap of 25.73M, ADVAXIS(ADXS) trades at $0.06.
On 2026-02-22, ADVAXIS(ADXS) stock opened at —, reached a high of —, and a low of —.
ADVAXIS(ADXS) shares are trading with a volume of 0, against a daily average of 14.19K.
In the last year, ADVAXIS(ADXS) shares hit a 52-week high of $0.80 and a 52-week low of $0.00.
In the last year, ADVAXIS(ADXS) shares hit a 52-week high of $0.80 and a 52-week low of $0.00.
People also own
Based on the portfolios of people who own ADXS. This list is generated using Robinhood data, and it’s not a recommendation.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.